Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0003873 (rheumatoid arthritis)
 53,068 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In 62 patients with seropositive rheumatoid arthritis, treated with gold compounds, the relationship between serological and clinical response was analysed, based on data on the rheumatoid factor (RF) titre, ESR, number of swollen joints and joint tenderness, through 3 years. Three groups were distinguished. The RF titre became normal in 19, remained elevated in 22, became normal and subsequently again elevated in 21. Responders and non-responders to chrysotherapy occurred in all 3 groups. The findings suggest involvement of pathogenetic mechanisms related to IgM-RF, and of pathogenetic mechanisms which are not related to IgM-RF, and which may be responsive or unresponsive to chrysotherapy.
 ...
PMID:Waaler Rose titres may decrease but increase again during chrysotherapy. 323 60

Ridaura was given to 72 patients with true rheumatoid arthritis (RA) in the period of 6 mos to 2 yrs. Patients with I-II degree of activity and II-III x-ray stage of RA prevailed. Extraarticular RA manifestations were detected in 79% of the patients. The efficacy of Ridaura was assessed by its effect on the indices of activity (clinical manifestations of the articular syndrome, ESR, morphological signs of rheumatoid synovitis) and progression (the rates of erosive arthritis development in the hand and foot joints, the time course of the level of the serum rheumatoid factor and RA systemic manifestations). The drug efficacy was assessed with relation to the preceding variant of a RA course by the onset of treatment and after 3, 6, 12 and 18 mos. The results obtained indicated a high clinical efficacy of the drug and the presence of its basal activity which manifested itself in a good clinical effect by a decrease in the rates of x-ray progression, a serum RF level, the expression of morphological signs of synovitis and extraarticular RA manifestations, in particular myocarditis, diffuse interstitial pulmonary fibrosis, fever, and Aschoff's nodules. The therapeutic effect of the drug was on an increase in the period over 1 year. The highest efficacy of the drug was noted in RA with persistent activity of I-II degree or with activation up to II degree. Side-effects were revealed in 19% of the patients. Good tolerance of the drug was observed in 63% of the patients with a previous history of intolerance to parenteral gold drugs.
 ...
PMID:[The potentials of a peroral gold preparation (Ridaura) in treating rheumatoid arthritis based on prospective observation data]. 324 62

Radiographs of hands and feet were obtained from 125 consecutive patients with rheumatoid arthritis (RA) and the degree of destruction was assessed numerically on a 200-point scale using Larsen's standard radiographs as reference. The method is shown to possess a satisfactory degree of reproducibility. In 96 of these 125 patients, values of another 15 simultaneously determined clinical and biochemical variables were obtained. On applying linear and quadratic multiple regression analysis to this set as well as to the male and female subsets, an 'automatic' selection procedure (stepwise regression) proved duration of disease to be the most important factor relating to the 'Larsen index'. The 96 patients were therefore ranked with respect to duration of disease and divided into 4 subsets of equal magnitude. In the 3 subsets with duration of disease less than 21 years, stepwise regression produced in the final step linear or quadratic combinations not containing duration of disease but correlating quite well with the 'Larsen index' (R = 0.64-0.96). A similar result was obtained upon performing an analogous procedure in the female subset. In all instances, positive contributions of varying degree were obtained from Ritchie's index, ESR, a-antitrypsin (A1-AT), orosomucoid, fibrinogen, and IgM, while negative correlations were associated with ceruloplasmin, IgG, and IgA.
 ...
PMID:Radiographic assessment in relation to clinical and biochemical variables in rheumatoid arthritis. 326 30

Rheumatoid arthritis (RA) is a common disabling disease. We are only just developing the necessary skills to assess the outcome of RA in both the short and long term. We can measure outcome in terms of radiological change, functional capacity and death. Patterns of disease onset and process measures, such as ESR and CRP, help to predict outcome. Without satisfactory methods of documenting the natural history of RA we cannot hope to be able to identify effective therapies or to develop sensible policies for their use.
 ...
PMID:Setting the scene and posing the questions. 327 81

Timegadine is a tri-substituted guanidine derivative which inhibits both arachidonate cyclo-oxygenase and lipoxygenase activity. In a 24-week randomized double-blind controlled trial, timegadine 500 mg/day was compared with naproxen 750 mg/day in two groups of 20 patients with active rheumatoid arthritis. In the timegadine group, significant improvements were seen in both biochemical and clinical markers of disease activity, i.e. ESR, serum IgG and IgM, leukocyte and platelet counts, duration of morning stiffness, Ritchie index, number of swollen joints, pain, and general condition. In the naproxen group, only the Ritchie index improved. Differences between treatments, when present, were always in favour of timegadine. Serum alkaline phosphatase rose during the first 8 weeks of treatment in the timegadine group. A transient rise was also seen in the naproxen group. The side effects reported were mainly gastrointestinal and allergic, the latter being more frequently found in the timegadine group. Timegadine is superior to naproxen in controlling disease activity in rheumatoid arthritis, and appears to possess disease-modifying properties.
 ...
PMID:Timegadine: more than a non-steroidal for the treatment of rheumatoid arthritis. A controlled, double-blind study. 329 Oct 99

Seventy-two patients with relatively early but progressive rheumatoid arthritis were treated with chloroquine sulphate, D-penicillamine or a combination of both drugs over 1 year. Chloroquine resulted in significantly fewer side-effects but combined treatment appeared to increase the risks of toxicity. Significant clinical improvements were seen with each regimen and these were indistinguishable between treatments. However, chloroquine had less impact on haemoglobin, ESR, rheumatoid factor levels and C-reactive protein than the other treatments. Furthermore, radiological deterioration was most frequent amongst those given chloroquine alone. Combination treatment with D-penicillamine and chloroquine thus offered no advantages. Chloroquine caused fewer side-effects than both D-penicillamine and combination treatment but appeared to have a less pronounced effect on the disease process as measured by laboratory and radiological indices.
 ...
PMID:Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study. 330 Aug 34

Although low-dose oral corticosteroid therapy cannot be considered remittive, it has earned a place in the therapeutic armamentarium for rheumatoid arthritis. Major clinical trials of a group using corticosteroid compared with a control group have not been done since the 1950s. One of these three large trials showed some slowing of the destructive joint changes of rheumatoid arthritis with use of low doses of corticosteroid. However, these agents have well-known side effects, especially when used long-term. Elderly patients or those who have features of the disease that indicate progression (eg, multiple joint involvement, elevated ESR, early evidence of erosion on x-ray films) are likely to benefit from carefully controlled doses of a corticosteroid. Because these drugs diminish bone formation and arthritis itself accelerates osteoporosis, supplemental calcium and vitamin D are useful adjuncts. A remittive agent and aspirin-like drug should be prescribed along with the corticosteroid. Abrupt withdrawal of even a very low dose of corticosteroids in rheumatoid arthritis patients causes a flare.
 ...
PMID:Oral steroids in rheumatoid arthritis. Helpful but not remittive. 331 40

Seventy-one patients with active rheumatoid arthritis were treated with one of five second-line agents and monitored for 24 weeks using seven clinical and seven laboratory measurements. Statistical tests were used to determine which measures changed fastest, which changed most and which most closely reflected changes in the others. The results consistently showed that articular index and summated change score were the 'best' clinical measures while ESR and plasma viscosity were the 'best' laboratory measures. Traditional measures such as grip strength and joint size fared badly and cannot be recommended. Clinical variables improved slightly more rapidly than laboratory measures, but the latter showed the greater change.
 ...
PMID:What are the 'best' measurements for monitoring patients during short-term second-line therapy? 333 28

Rheumon-Gel was used for therapy of 51 patients with rheumatoid arthritis. It has been shown that the drug has a marked antiinflammatory and analgesic action, a positive effect on a number of subjective (pain in the joints and constrained movements in the morning), objective (body temperature, edema and joint function), and laboratory (leucocyte count, ESR, C-reactive protein, titer of antistreptolysin-O and antistreptohyaluronidase) indices and therefore it can be recommended for multimodality therapy of rheumatic patients, particularly of those with rheumatoid arthritis combined with G. I. tract diseases when the use of most of the antirheumatic drugs is counterindicated.
 ...
PMID:[Topical use of Rheumon-Gel in the combined treatment of patients with rheumatoid arthritis]. 344 80

The aims of this thesis were to investigate individuals with rheumatoid arthritis (RA) with respect to the frequency and character of temporomandibular joint (TMJ) disorder, the relationship between TMJ involvement and general joint disease, the possibility to detect pathologic conditions in the TMJ region with skin surface temperature, and treatment effect of physical training on TMJ disorder. TMJ disorder was more frequent and more severe in RA than among normal subjects. The TMJ symptoms started frequently in the early phase of RA and were correlated to the extension of the general joint symptoms. Anterior open bite occurs in a small subgroup of RA individuals and was associated with severe TMJ disorder and high values of ESR. High concentration of serum acute-phase reactants and high values of rheumatologic indices were associated with severe TMJ involvement in RA. Skin surface temperature over the TMJ and the masseter muscle was generally low in individuals with RA compared with normal subjects. TMJ disorder was related to the overlying skin surface temperature. The low temperature over the TMJ and the masseter muscle is probably caused by disuse atrophy and an ensuing decrease in muscular blood flow. Short-term results of physical training for the stomatognathic system improved the mandibular mobility and reduced the clinical dysfunction in RA.
 ...
PMID:Temporomandibular joint involvement in rheumatoid arthritis. A clinical study. 348 Jun 11


<< Previous 1 2 3 4 5 6 7 8 9 10